Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 1176Cisplatin 893Pemetrexed 849pembrolizumab 627Paclitaxel 610Docetaxel 539Gemcitabine 428Radiotherapy 393Erlotinib Hydrochloride 381Nivolumab 344Bevacizumab 337Etoposide 297durvalumab 265Drug Therapy 260osimertinib 237atezolizumab 225Radiosurgery 196Gefitinib 186Vinorelbine 149Magnetic Resonance Spectroscopy 132Ipilimumab 129130-nm albumin-bound paclitaxel 125Cetuximab 113anlotinib 106Blood Specimen Collection 106tislelizumab 104Topotecan 103Specimen Handling 102Surgical Procedures, Operative 101Cyclophosphamide 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genes, fms × Thoracic × Clear all
NCT04806412 2022-05-17

Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.

Naestved Hospital

Phase NA Unknown
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡